US HB5587 | 2013-2014 | 113th Congress
Status
Spectrum: Partisan Bill (Democrat 6-0)
Status: Introduced on September 18 2014 - 25% progression, died in committee
Action: 2014-09-19 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 18 2014 - 25% progression, died in committee
Action: 2014-09-19 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Opioid Abuse Prevention and Treatment Act of 2014 - Requires the Secretary of Health and Human Services (HHS) to award grants to states to develop a peer review process to identify and investigate questionable or inappropriate prescribing and dispensing patterns of drugs classified as schedule II or III under the Controlled Substances Act, which are drugs with an accepted medical use that have the potential to be abused and addictive. Amends the Public Health Service Act to require the Secretary to establish grant programs to: (1) facilitate training to increase the capacity of health care providers to screen and treat patients to prevent drug abuse, and (2) develop continuing education criteria that allow health profession boards or state agencies to certify appropriate education for safe prescribing of schedule II or III drugs. Requires the Administrator of the Health Resources and Services Administration to award grants to evaluate the prospect of state health professions boards expanding the authority of providers to prescribe drugs to treat drug abuse. Requires the Attorney General to request that practitioners registered to dispense controlled substances screen patients for potential drug abuse before prescribing a schedule II or III drug. Directs the Food and Drug Administration (FDA) to consider whether naloxone (a prescription drug used to rapidly reverse an overdose of heroin or other opioids, which are drugs with effects similar to opium) should be available without a prescription. Requires the Secretary to use an interagency working group to encourage states and local governments to increase opportunities for disposal of opiates (drugs derived from opium) and to reduce opportunities for abuse of opiates. Requires the Government Accountability Office (GAO) to review federal opioid abuse activities and make recommendations to reduce opioid abuse and overdoses.
Title
Opioid Abuse Prevention and Treatment Act of 2014
Sponsors
Rep. Bill Foster [D-IL] | Rep. Donna Edwards [D-MD] | Rep. Elizabeth Esty [D-CT] | Rep. Sean Maloney [D-NY] |
Rep. Tim Ryan [D-OH] | Rep. Carol Shea-Porter [D-NH] |
History
Date | Chamber | Action |
---|---|---|
2014-09-19 | House | Referred to the Subcommittee on Health. |
2014-09-18 | House | Referred to the House Committee on Energy and Commerce. |
Subjects
Congressional oversight
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Education programs funding
Emergency medical services and trauma care
Government studies and investigations
Health
Health care coverage and access
Health care quality
Health information and medical records
Health personnel
Health programs administration and funding
Health promotion and preventive care
Medical education
Medical ethics
Medical tests and diagnostic methods
Prescription drugs
Solid waste and recycling
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Education programs funding
Emergency medical services and trauma care
Government studies and investigations
Health
Health care coverage and access
Health care quality
Health information and medical records
Health personnel
Health programs administration and funding
Health promotion and preventive care
Medical education
Medical ethics
Medical tests and diagnostic methods
Prescription drugs
Solid waste and recycling
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/113th-congress/house-bill/5587/all-info |
Text | https://www.congress.gov/113/bills/hr5587/BILLS-113hr5587ih.pdf |